Annual Symposium
Each Fall the Institute for Drug Discovery presents a symposium which provides exceptional speakers from around the country, while also showcasing faculty research and providing an opportunity for collaborations to begin.
2023 - 8th Annual Symposium
Friday, October 6, 2023 in the Stewart Center
Keynote Speakers included:
Lieping Chen - "Targeting immunotherapy to the tumor microenvironment"
Bryan Roth - "Illuminating the receptors of perception"
Daniel Nomura - "Reimagining Druggability using Chemoproteomic Platforms"
2022 - 7th Annual Symposium
Friday, September 30, 2022 in the Stewart Center
Keynote Speakers included:
Brian Blagg - "From Pan to Selective Inhibition of Hsp90: New Therapies for Cancer, Glaucoma, and CNS Disorders"
Gunda Georg - "Retinoic Acid Receptor Antagonist for Non-hormonal Male Contraception"
Phil Low - "A New Generation of Targeted Therapies"
2020 - 2021
In order to ensure the safety of our symposium attendees, the 2020 and 2021 annual symposiums were cancelled due to the SARS-CoV-2 pandemic.
2019 - 6th Annual Symposium
Monday, October 14 in the Buchanan Club at Ross-Ade Stadium
Keynote Speakers included:
Dennis Liotta - "Novel Therapeutics for Treating Viral Diseases, Cancers, and Inflammatory Diseases"
Nathanael Gray - "Small Molecule Directed Protein Degradation - a New Paradigm for Drug Discovery"
Jun Liu - "Discovery of New Drugs from Known Drugs and Natural Products"
2018 - 5th Annual Symposium
Friday, September 28 in Stewart Center
Keynote Speakers included:
Min Li - "Neuroscience Therapeutics through the 2020 lens"
Philip Cole - "AKTivation Mechanisms"
Shaomeng Wang - "Targeting Protein Degradation for New Therapeutics"
2017 - 4th Annual Symposium
Wednesday, October 11 in the North Ballroom of the Purdue Memorial Union
Keynote Speakers included:
Richard DiMarchi
Michael Jensen
2016 - 3rd Annual Symposium
Friday, September 30 in the Buchanan Club at Ross-Ade Stadium
Keynote Speakers included:
Richard Silverman
Nicholas Meanwell
Daniel Powell
2015 - 2nd Annual Symposium
Friday, September 18 in the Burton D. Morgan Center for Entrepreneurship
Keynote Speakers included:
Ben Shen - "Microbial Genomics: New Opportunities for Natural Product Biosynthesis, Engineering, and Drug Discovery"
Xu Liang - "Undruggable: New Frontiers in Precision Medicine"
Susan Mooberry - "Semi-Synthesis from the Bat Flower: Source of Next Generation Microtubule Stabilizers"
Jesse Rinehart - "Reengineering Protein Phosphorylation to Target Cancer"
2014 - 1st Annual Symposium
Thursday, September 4 in the Burton D. Morgan Center for Entrepreneurship
Keynote Speakers included:
Paul Hergenrother - "Procaspase-3 Activation as an Anticancer Strategy. From compound Discovery to Human Clinical Trial"
Phil Hipskind - "Hedgehog Pathway Inhibitors for the Treatment of Cancer"
Dong Wang - "Glucocorticoid Prodrug Development for Inflammatory Disease"
Chris Hulme - "Expediting Drug Discovery in Academia Through Enabling Chemistry"